Professor of Medicine (Medical Oncology) and of Urology; Chief, Genitourinary Oncology
As Professor of Medicine and Urology at Yale School of Medicine, Dr. Daniel P. Petrylak is a pioneer in the research and development of new drugs and treatments to fight prostate, bladder, kidney and testicular cancer. For patients fighting these types of cancers, Petrylak finds recent developments in the field of immunotherapy particularly promising. “Up until recently, bladder cancer had not seen any major advancement in more than 30 years,” he says. “Studies are ongoing, but interim results are exciting so far.”At the Smilow Cancer Hospital, Dr. Petrylak’s position as a national leader on clinical trials for men with prostate and bladder cancer has opened up a world of treatment options for patients in New England. “We offer the latest investigational drugs for these conditions, while providing the highest level of care,” he says.Dr. Petrylak received his MD from Case Western Reserve...
Professor of Pathology; Director of Cytopathology; Director, Cytology Laboratory; Director, Cytopathology Fellowship Program, Pathology; Director, Anatomic Pathology Elective Program, Pathology
Dr. Adebowale Adeniran is an experienced surgical pathologist and cytopathologist, and currently Director of Cytopathology and the Cytology Laboratory and Director of Cytopathology Fellowship Program. Dr. Adeniran obtained his MD degree from the University of Ibadan, Nigeria. He did his anatomic/clinical pathology residency at the University of Cincinnati Medical Center, followed by surgical pathology fellowship (with special interest in genitourinary pathology) at the University of Texas M.D. Anderson Cancer Center and cytopathology fellowship at the Memorial Sloan-Kettering Cancer Center. Dr. Adeniran is a practicing surgical and cyto pathologist, with a research focus on clinico-pathologic and molecular pathologic aspects of kidney cancer as well as thyroid cancer. He is an editorial board member of Cancer Cytopathology and Journal of Clinical and Translational Pathology, and a...
Assistant Professor of Therapeutic Radiology; Chief, Genitourinary Radiotherapy Program, Therapeutic Radiology; Chief, Spine Radiotherapy Program, Therapeutic Radiology
Dr. An received his medical degree from Stanford University of School of Medicine and continued his specialty training in Radiation Oncology at Yale University School of Medicine and Yale New Haven Hospital. He served as chief resident prior to joining the faculty as Assistant Professor. Dr. An is primarily based in Smilow Cancer Hospital Care Center in New Haven, CT and Trumbull, CT. His areas of clinical expertise and specialization include prostate cancer, bladder cancer, brain/spine radiosurgery, and brain cancers.
Demetrios Braddock was born in Tennessee, educated at the University of Chicago, trained at the NIH in Anatomic Pathology and Biophysical Chemistry, and came to Yale in 2004 where he practices hematopathology and heads a laboratory studying pathogenic mechanisms of severe and poorly addressed human diseases. His laboratory focuses on rare diseases of children, and on the design and engineering of novel biologics to modulate disease outcomes. Dr. Braddock’s laboratory has designed and validated an enzyme biologic for a lethal infantile calcification disorder called ‘Generalized Arterial Calcification of Infancy’ (GACI), which has been translated into infants, children, and adults with GACI, ARHR2, PXE, and CKD-MBD (ClinicalTrials.gov: NCT05734196, NCT06046820, NCT04686175, NCT06283589).
Professor of Urology; Director of Urologic Oncology, Urology
Dr. John W. Colberg is a graduate of Washington University School of Medicine and Yale University School of Medicine Urology Residency Program. He was a Clinical Instructor at Washington University School of Medicine from 1990 to 1998. He is currently a Professor of Urology and Director of Uro-Oncology in the department of Urology at Yale University School of Medicine. His active clinical practice focuses on urologic oncology with an emphasis on bladder and prostate cancer. Dr. Colberg’s primary research interests are in the area of invasive bladder cancer and bladder reconstruction. Watch a video with Dr. John Colberg>>
Associate Professor of Medicine (Medical Oncology); Clinical Research Team Leader Sarcoma, Medical Oncology; Director Medical Oncology Inpatient Consult Service, Medical Oncology
Dr. Hari Deshpande, Associate Professor of Medicine in the Section of Medical Oncology, cares for patients with sarcomas along with the sarcoma multidisciplinary team.Previously in practice at both the New London Cancer Center and Las Vegas Cancer Center, Dr. Deshpande also has clinical interests in sarcomas, cancers of unknown primary, and thyroid cancers. He is a member of the Head and Neck Cancer and GU cancer teams. He is the Director of the Medical Oncology Inpatient Consult service.Learn more about Dr. Deshpande>>
Clinical Interests: Female urology, urodynamics, neurogenic bladder, male and female urinary incontinence, interstitial cystitis; voiding dysfunction; benign prostatic hyperplasia, erectile dysfunction, urologic cancers.Dr. Harris E. Foster Jr. is board certified in urology and has specialized interests in voiding dysfunction and female urology. Particular to this area include treatment of female and male urinary incontinence, neurogenic bladder, benign prostatic hyperplasia (BPH), interstitial cystitis, urethral diverticula and vesicovaginal fisulae. In addition, Dr. Foster treats general urological conditions such as kidney stones, erectile dysfunction, prostate cancer, superficial bladder cancer, and benign conditions involving the scrotum (hydrocele, epididymal cyst). He also performs circumcision and vasectomy in patients who desire these procedures. Dr. Foster has expertise in the evaluation of...
Practice locations: New Haven, Hamden, Madison, Old SaybrookResidency Institution: New York Hospital- Cornell Medical CenterFellowship: Cornell University Medical College 1986-1987Clinical Interests: Management of prostate, bladder, kidney, testes, adrenal, penile cancer; Pelvic and retroperitoneal sarcoma; Minimally invasive robotic surgery; Complex intestinal urinary diversionDr David Hesse is a board certified urologist. He graduated from the University of New Mexico School of Medicine with the Faculty Award for Excellence, before completing his surgical and urological training at New York Hospital-Cornell Medical College. During his research fellowship at Cornell Medical College/Rockefeller University he was part of the team instrumental to the discovery of Tumor Necrosis Factor. Dr Hesse came to New Haven in 1991 to develop a urology practice treating patients...
Professor of Pathology; Director, Genitourinary Pathology, Pathology
Peter A. Humphrey, M.D., Ph.D. obtained his B.A. in Chemistry and Biochemistry, and his MD and PhD (in biochemistry) from The University of Kansas. He did his anatomic pathology residency at Duke University Medical Center, and joined the faculty there for four years, followed by 21 years as a faculty member at Washington University School of Medicine. Dr. Humphrey is a practicing surgical and urologic pathologist, with a research focus on clinico-pathologic and molecular pathologic aspects of prostate cancer. He is on the editorial boards of The American Journal of Surgical Pathology, Modern Pathology, and Human Pathology. He has 361 publications, has authored the textbook Prostate Pathology, co-authored the textbook Gleason Grading of Prostate Cancer, co-authored the AFIP Fascicle on the Prostate, co-authored the textbook Neoplastic Mimics in Genitourinary Pathology, is co-editor of...
Professor of Radiology and Biomedical Imaging; Chief, Body Imaging Section; Chief, Body Computed Tomography (CT)
Gary Israel, MD, Professor and Section Chief of Abdominal Section. Dr. Israel earned his medical degree at New York Medical College, and completed a residency and fellowship in diagnostic radiology at Montefore Medical Center and New York University Medical Center, respectively.Dr. Israel’s expertise is abdominal imaging with a particular focus on genitourinary imaging (GU), using both CT and MRI. He has particular interest in the CT and MR evaluation of renal masses and CT and MR. He also has expertise in GI radiology including CT colonography.
Assoc Dean for Clinical Affairs and Chief Ambulatory Physician Executive
Clinical interests: Localized, locally advanced and metastatic kidney cancer. Robotic surgery for kidney masses and kidney cancer. Robotic partial and radical nephrectomy, including robotic IVC tumor thrombectomy. Complex partial and radical nephrectomy. Caval tumor thrombectomy. Cytoreductive nephrectomy. Retroperitoneal lymphadenectomy. Renal Cell Carcinoma. Patrick Kenney, MD is a urologic oncologist who cares for patients with cancers of the kidney. He performs robotic and open surgery for kidney cancer, with an emphasis on organ/function preservation and minimally invasive surgery whenever feasible. He is interested in the integration of surgery and systemic therapy for locally advanced, metastatic, and treatment-resistant kidney cancer. In his clinical practice, Dr. Kenney emphasizes the importance of the doctor-patient relationship. Dr. Kenney believes in the importance of...
Professor of Urology; Chair, Urology; Chief, Urology; Co-Leader, Cancer Signaling Networks, Yale Cancer Center
Dr. Isaac Kim is a urologic oncologist and surgeon who specializes in the treatment, management, and prevention of prostate cancer, with the goal of helping patients navigate and better understand their disease. He has expertise in minimally invasive robotic surgery and has completed more than 2,400 robotic surgeries for prostate cancer. Dr. Kim's surgical focus has been on advanced and metastatic prostate cancer, as well as recurrent disease after radiation. Dr. Kim’s clinical research is focused on mechanisms of treatment resistance and specifically immunosuppressive factors produced by prostate cancer cells. He also has a strong interest in inflammation in prostate cancer and the role of surgery in men with advanced or metastatic prostate cancer.
Associate Professor of Internal Medicine (Medical Oncology); Director, Prostate Cancer Research; Lecture Coordinator in Hematology/Oncology, Yale Affiliated Hospital Program
Dr. Joseph Kim is a board-certified medical oncologist and a Director of the Prostate Cancer Research Program for Prostate and Urological Cancers DART of Yale Cancer Center. He is a recipient of the Cancer Clinical Investigator Team Leadership Award from the National Cancer Institute (NCI) and a recipient of other awards from Conquer Cancer Foundation of the American Society of Clinical Oncology (ASCO). Dr. Kim has led several peer-reviewed, NCI-sponsored, investigator-initiated clinical trials in prostate cancer, bladder cancer, and other solid tumors as a study chair. Dr. Joseph Kim serves as an author/editor of the genitourinary (GU) cancers chapter of ASCO-SEP, an educational textbook for medical oncologists, and a co-editor of the GU cancers section of a peer-reviewed journal, Current Oncology Report, and ad hoc reviewer of multiple oncology journals. He has been invited...
Harvey and Kate Cushing Professor of Medicine (Oncology) and of Dermatology; Director, Yale SPORE in Skin Cancer, Yale Cancer Center; Vice Chair for Collaborative Research, Internal Medicine; Chief, Division of Skin and Kidney Cancer; Associate Cancer Center Director, Education, Training and Faculty Development; Deputy Section Chief, Medical Oncology
Dr. Kluger is a medical oncologist who sees patients with melanoma and renal cell carcinoma. Her research interests focus on developing new drug regimens and biomarkers predictive of response to therapies in melanoma and renal cell carcinoma. She participates in a number of clinical trials studying new agents for the treatment of these diseases, both targeting the immune system and the cancer cell. She runs an active research laboratory that studies tumor and immune cells from patients treated with novel therapies to determine mechanisms of resistance to therapy and mediators of toxicity from immune checkpoint inhibitors. The laboratory also conducts pre-clinical studies to improve treatment regimens for patients with melanoma, renal cell carcinoma or brain metastasis. Please visit the lab website at: https://sites.google.com/yale.... Learn more about Dr. Kluger>>
Darryl T. Martin is a basic scientist with a strong background in translational science. Dr. Martin received his PhD from Memorial University of Newfoundland under the supervision of Drs. Robert Gendron and Hélène Paradis where he trained as a cancer molecular biologist studying tumor growth and differentiation. He then trained with Dr. Robert M. Weiss (Donald Guthrie Professor of Urology) at the Yale University School of Medicine, as a Postdoctoral Associate, where he focused on drug delivery and cancer progression. Currently, Dr. Martin is an Assistant Professor in the Department of Urology at the Yale School of Medicine. His laboratory primarily focuses on biological factors and molecular determinants that drive disease progression and metastatic formation through their interaction with the tumor microenvironment. Dr. Martin is a member of the American Association for Cancer...
Associate Professor of Urology; Vice Chair of Clinical Affairs, Urology
Practice locations: Orchard Street Campus, Hamden and Madison Residency: Yale-New Haven Hospital Fellowship: New York Hospital/Cornell University Medical Center Clinical interests: General Urology, Robotic Surgery and Laparoscopy, Urologic OncologyThomas V. Martin, MD is a native of Connecticut who received a Bachelor of Science (Phi Beta Kappa, Magna Cum Laude) from Georgetown University in Washington, DC. He then received his MD from the University of Connecticut School of Medicine. After medical school, he completed a residency in urology at Yale-New Haven Hospital. After residency, he obtained a fellowship in Endourology and minimally invasive surgery at the New York Hospital/Cornell University Medical Center in New York.Since completing his fellowship in 1996, Dr. Martin has been in practice in New Haven. His practice has focused on minimally invasive surgical approaches to...
Associate Professor of Urology; Endourology Chief, Urology; Director, Laparoscopy & Endourology, Urology; Director, Endourology Fellowship, Urology
Dinesh Singh, MD, Associate Professor of Urology and Director of Laparoscopy and Endourology, earned his medical degree from Columbia University and completed his residency in general surgery at Brigham & Women’s Hospital and his residency in urology at Harvard Medical School. Dr. Singh is Board Certified in Urology and completed fellowship training in laparoscopy and minimally invasive surgery. He specializes in treating patients with prostate cancer, adrenal gland tumors, ureteropelvic junction (UPJ) obstruction, testes cancer, and kidney stone disease. Dr. Singh is committed to helping patients with urologic conditions experience faster post-surgical recovery time, shorter hospital stays, and minimal scarring from incisions. He has extensive surgical expertise in advanced minimally invasive procedures, including laparoscopic partial and full nephrectomy, laparoscopic...
Associate Professor of Urology; Director, Urology Research Fellowship, Urology; Co-Chair, Cancer Liaison Committee, Oncology, VA Connecticut Healthcare System; Co-Chair, NCCN Guidelines Committee on Prostate Cancer Early Detection, National Comprehensive Cancer Network (NCCN); Division Chief, Division of Urology at VA Connecticut Healthcare System, Urology, VA Connecticut Healthcare System; Chair, Robotic Surgery Advisory Board, National Surgery Office
Dr. Preston C. Sprenkle specializes in the treatment of urologic cancers, primarily prostate cancer, but also including kidney cancer, bladder cancer, and testicular cancer. Dr. Sprenkle has dedicated his career to using the latest technologies to improve prostate cancer diagnosis and treatment that minimizes the impact on a man's quality of life. He was one of the first physicians nationwide to implement the use of the Artemis Device. This machine, introduced in 2009, allows a surgeon to use 3D ultrasound technology and merge it with even more precise magnetic resonance imaging (MRI) to accurately identify cancerous tumors. “Skilled and experienced radiologists are rare for this relatively new technique,” Dr. Sprenkle explains. “At Yale, we are fortunate to have some of the world leaders in prostate MRI.” Dr. Sprenkle is also a pioneer in “focal therapy,” which allows a surgeon to treat tiny...
Professor Emeritus of Radiology and Biomedical Imaging
Dr. Jeffrey C. Weinreb is Director of the MRI Service at Yale-New Haven Hospital and Professor in the Department of Radiology and Biomedical Imaging at the Yale School of Medicine. After graduating Phi Beta Kappa from the MIT, he received his MD from the Icahn School of Medicine at Mount Sinai. He has held faculty positions at UT Southwestern Medical School, Columbia College for Physicians and Surgeons, and NYU School of Medicine, where he was Director of MRI for 15 years and led a group that pioneered the development of Body MRI. For more than three decades, Dr. Weinreb has been an innovator in MRI. He is a leading authority on MRI contrast agents and MRI safety, and he has made seminal contributions to clinical applications of MRI in the abdomen, spine, breast, prostate, breast, vascular system, obstetrics, and gynecology. He has authored/co-authored three textbooks and more...